130 related articles for article (PubMed ID: 2581902)
1. Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations.
Epstein AL; Variakojis D; Berger C; Hecht BK
Int J Cancer; 1985 May; 35(5):619-27. PubMed ID: 2581902
[TBL] [Abstract][Full Text] [Related]
2. Biology and virology of the human malignant lymphomas: 1st Milford D. Schulz Lecture.
Kaplan HS; Goodenow RS; Gartner S; Bieber MM
Cancer; 1979 Jan; 43(1):1-24. PubMed ID: 83902
[TBL] [Abstract][Full Text] [Related]
3. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines.
Epstein AL; Kaplan HS
Cancer Res; 1979 May; 39(5):1748-59. PubMed ID: 371794
[TBL] [Abstract][Full Text] [Related]
4. Histiocytic lymphoma cell lines: immunologic and cytogenetic studies.
Hecht BK; Epstein AL; Berger CS; Kaplan HS; Hecht F
Cancer Genet Cytogenet; 1985 Jan; 14(3-4):205-18. PubMed ID: 3881165
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 14 translocation in African and North American Burkitt's lymphoma;
Kaiser-McCaw B; Epstein AL; Kaplan HS; Hecht F
Int J Cancer; 1977 Apr; 19(4):482-6. PubMed ID: 844916
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation.
Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y
Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659
[TBL] [Abstract][Full Text] [Related]
8. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
9. A translocation (8;14) in a cutaneous large B-cell lymphoma.
Busschots AM; Geerts ML; Mecucci C; Stul M; Cassiman JJ; van den Berghe H
Am J Clin Pathol; 1993 May; 99(5):615-21. PubMed ID: 8388165
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of three new malignant lymphoid cell lines.
Th'ng KH; Garewal G; Kearney L; Rassool F; Melo JV; White H; Catovsky D; Foroni L; Luzzatto L; Goldman JM
Int J Cancer; 1987 Jan; 39(1):89-93. PubMed ID: 3098690
[TBL] [Abstract][Full Text] [Related]
11. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
12. A novel Japanese Burkitt's lymphoma cell line, P32/Ishida, with a new variant chromosomal translocation (2;14).
Hirose M; Minato K; Tobinai K; Ise T; Watanabe S; Shimoyama M; Abe T
Gan; 1983 Dec; 74(6):878-86. PubMed ID: 6667834
[TBL] [Abstract][Full Text] [Related]
13. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and cytogenetic characteristics of a new Epstein-Barr virus negative cell line (SKW 4) derived from a B-cell lymphoma.
Nilsson K; Klareskog L; Ralph P; Sundström C; Zech L
Hematol Oncol; 1983; 1(4):277-95. PubMed ID: 6329938
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphomas with band 8q24 chromosome abnormality: a morphologic continuum extending from Burkitt's to immunoblastic lymphoma.
Sigaux F; Berger R; Bernheim A; Valensi F; Daniel MT; Flandrin G
Br J Haematol; 1984 Jul; 57(3):393-405. PubMed ID: 6547618
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantation.
Nozawa Y; Abe M; Wakasa H; Ohno H; Fukuhara S; Kinoshita T; Osato T
Tohoku J Exp Med; 1988 Dec; 156(4):319-30. PubMed ID: 2854303
[TBL] [Abstract][Full Text] [Related]
19. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
Berger R; Bernheim A
C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
[TBL] [Abstract][Full Text] [Related]
20. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
